AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17224434
Drug: Control (C)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (C) - no particular preparation
Trial: 9135194
Drug: Clonidine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (5 micrograms.kg‐1) administered orally 90 min before surgery
Trial: 2405613
Drug: Nicardipine (60-90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (60-90 mg/day)
Trial: 2405613
Drug: Nicardipine (30-90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (30-90 mg/day)
Trial: 2405613
Drug: Nicardipine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (mean dose 69.4 mg/day)
Trial: 2405613
Drug: Nicardipine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (60 mg/day)
Trial: 31688431
Drug: Oral bicarbonate
RxNorm normalized name: sodium bicarbonate Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bicarbonate on top of hydration
Trial: 31688431
Drug: Intravenous bicarbonate
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bicarbonate on top of hydration
Trial: 24521895
Drug: Trial group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trial group (n = 24) received solifenacin succinate (5 mg, once a day) and naftopidil (25 mg, every evening)
Trial: 16949486
Drug: Metformin 500
RxNorm normalized name: metformin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 500 mg twice a day (n = 16)
Trial: 10823767
Drug: Oral inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral inactivated whole cell Vibrio cholerae plus recombinant B subunit cholera vaccine
Trial: 6441194
Drug: Photons (subgroup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photons (subgroup treatment for larynx cancer)
Trial: 18361754
Drug: Pickles (PCK)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pickles (PCK) (approximately 1,400 mg of acetic acid daily)
Trial: 18361754
Drug: Vinegar (VIN)
DrugBank: Acetic acid (DB03166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vinegar (VIN) (2,800 mg of acetic acid daily)
Trial: 18361754
Drug: Commercial vinegar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial vinegar pills (REF) (30 mg of acetic acid daily)
Trial: 12766653
Drug: Ropivacaine 0.2%
RxNorm normalized name: ROPivacaine 0.2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.2% with 30 mg of ketorolac
Trial: 9664951
Drug: Anti-thymocyte globulin
RxNorm normalized name: ANTI-THYMOCYTE GLOBULIN
DrugBank: Antilymphocyte immunoglobulin (horse) (DB09312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-thymocyte globulin (ATG) - 7 x 4 mg/kg body weight i.v.
Trial: 9664951
Drug: Methylprednisolone (MP)
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (MP) - 3 x 250 mg i.v.
Trial: 2785355
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion of propofol, 18 mg.kg‐1.h‐1 for the first 30 min and 15 mg.kg‐1.h‐1 thereafter
Trial: 28946866
Drug: Micronutrient powders
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronutrient powders (MNPs) given daily to caregivers of infants in the treatment group.
Trial: 23945720
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (25 mg Zn/d)
Trial: 20598480
Drug: Percutaneous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous treatment with ePTFE/nitinol self-expanding stent graft (n = 50)
Trial: 20598480
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment with femoral to above-knee popliteal artery bypass using synthetic conduit (n = 50)
Trial: 16697124
Drug: Propranolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (100 mg/day)
Trial: 16697124
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amantadine (300 mg/day) and propranolol (100 mg/day)
Trial: 12743863
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) using the photosensitizer SQN 400 and interstitial photodynamic laser treatment
Trial: 12743863
Drug: Photodynamic laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic laser therapy
Trial: 28904371
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose insulin infusion
Trial: 11302998
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose insulin infusion
Trial: 7908410
Drug: High-dose adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose adjuvant chemotherapy (cyclophosphamide, doxorubicin, and fluorouracil)
Trial: 7908410
Drug: Moderate-dose and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-dose and low-dose adjuvant chemotherapy (cyclophosphamide, doxorubicin, and fluorouracil)
Trial: 3265525
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg fluoxetine
Trial: 3265525
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg amitriptyline + 5 mg diazepam
Trial: 3265525
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + 5 mg diazepam
Trial: 332196
Drug: Cycloalliin, single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cycloalliin, single oral dosage
Trial: 25675384
Drug: RM-493 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RM-493 (1 mg/24 h)
Trial: 22397264
Drug: Food supplement
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Food supplement containing D‐phenylalanine, L‐glutamine and L‐5‐hydroxytriptophan
Trial: 19715914
Drug: Sirolimus with
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus with Cyclosporine and Steroids (SRL-CsA-ST)
Trial: 19715914
Drug: Sirolimus with
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus with Steroids after Cyclosporine withdrawal (SRL-ST)
Trial: 18236765
Drug: Gout treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gout treatment with colchicine
Trial: 9886905
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS 30 mg daily
Trial: 9886905
Drug: Co-amilozide (hydrochlorothiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-amilozide (hydrochlorothiazide 25 mg/amiloride 5 mg) once daily
Trial: 8057222
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg Zn++ as sulfate daily
Trial: 8057222
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg Zn++ as sulfate daily
Trial: 8057222
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg Zn++ as sulfate daily (control)
Trial: 29688617
Drug: Upadacitinib extended-release
RxNorm normalized name: upadacitinib Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upadacitinib extended-release (ER) formulation 15 mg once daily
Trial: 29688617
Drug: Upadacitinib extended-release
RxNorm normalized name: upadacitinib Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upadacitinib extended-release (ER) formulation 30 mg once daily
Trial: 29688617
Drug: Upadacitinib extended-release
RxNorm normalized name: upadacitinib Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upadacitinib extended-release (ER) formulation
Trial: 22900449
Drug: Atomized administration
RxNorm normalized name: Atomic Balm
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atomized administration of intranasal ketamine (INK)
Trial: 22900449
Drug: Drops administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drops administration of intranasal ketamine (INK)
Trial: 19455040
Drug: sugammadex 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sugammadex 2.0 mg/kg
Trial: 19455040
Drug: sugammadex 4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sugammadex 4.0 mg/kg
Trial: 30221619
Drug: Brief cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief cognitive-behavioural therapy
Trial: 22762867
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of tobramycin inhalation solution (TIS) for 28 days
Trial: 22762867
Drug: Inhaled sodium
RxNorm normalized name: Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled sodium colistimethate (2×2 millU/day) plus oral ciprofloxacin (30 mg/kg/day) for 3 months (CC)
Trial: 22762867
Drug: Inhaled sodium
RxNorm normalized name: Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled sodium colistimethate (CC) for 3 months
Trial: 22762867
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (TIS and CC)
Trial: 10485302
Drug: Separate injections
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate injections (n = 215)
Trial: 10485302
Drug: Single manually
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single manually reconstituted injection (n = 59)
Trial: 10485302
Drug: Dual-chamber syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-chamber syringe and separate injection methods
Trial: 31060834
Drug: Mixed meals
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed meals with 11 ml extra virgin olive oil
Trial: 26431847
Drug: Evidence-Based Medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-Based Medicine (EBM) program including a roundtable seminar on Depot Medroxy Progesterone Acetate (DMPA) and two 15 min one-on-one educational visits.
Trial: 21204827
Drug: Carbamazepine (CBZ)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ) 600 mg
Trial: 1541612
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (12 immediate and 3 delayed)
Trial: 1541612
Drug: Non-steroidal anti-inflammatory
RxNorm normalized name: Non-steroidal anti-inflammatory agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroidal anti-inflammatory medications
Trial: 3895963
Drug: Clotrimazole 500
RxNorm normalized name: clotrimazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clotrimazole 500 mg single-dose treatment
Trial: 3895963
Drug: Clotrimazole 200
RxNorm normalized name: clotrimazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clotrimazole 200 mg 3-day treatment
Trial: 30707661
Drug: Alisertib 50
RxNorm normalized name: Alisertib
DrugBank: Alisertib (DB05220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alisertib 50 mg two times per day (days 1 to 7; 21-day cycle)
Trial: 30707661
Drug: Investigator-selected single-agent
RxNorm normalized name: INVESTIGATIONAL AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigator-selected single-agent comparator (including intravenous pralatrexate 30 mg/m2 once per week for 6 weeks; intravenous gemcitabine 1,000 mg/m2; or intravenous romidepsin 14 mg/m2 days 1, 8, and 15; 28-day cycle)
Trial: 22356118
Drug: Olanzapine monotherapy
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine monotherapy (5-20 mg/day)
Trial: 18339043
Drug: Saline (Chauvin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (Chauvin Pharmaceuticals Ltd)
Trial: 10595868
Drug: Stavudine-containing triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stavudine-containing triple therapies
Trial: 10595868
Drug: Stavudine-containing combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stavudine-containing combination therapies
Trial: 8706777
Drug: Quinidine 200
RxNorm normalized name: quiNIDine 200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine 200 mg given 2 hours before codeine
Trial: 8706777
Drug: Quinidine 200
RxNorm normalized name: quiNIDine 200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine 200 mg
Trial: 8706777
Drug: Quinidine pre-treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine pre-treatment
Trial: 26472752
Drug: Obinutuzumab 1000
RxNorm normalized name: obinutuzumab 1000 MG in 40 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Obinutuzumab 1000 mg
Trial: 31603721
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection (Control)
Trial: 26843120
Drug: Red ginseng
RxNorm normalized name: Red ginseng
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red ginseng (5 g daily for 12 weeks)
Trial: 25259743
Drug: Paricalcitol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paricalcitol (2 μg/d for 12 weeks)
Trial: 17469680
Drug: New drug
RxNorm normalized name: varicella zoster immune globulin (Investigational New Drug)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drug (not specified)
Trial: 17469680
Drug: Standard agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard agent (not specified)
Trial: 7594425
Drug: Cyclosporin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (5 mg/kg twice a day)
Trial: 6195240
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g latamoxef
Trial: 31865134
Drug: Late AED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late AED withdrawal (continued on single AED for three years before discontinuation)
Trial: 29977328
Drug: Open abdomen
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open abdomen (OA) management with application of an active negative peritoneal pressure therapy (ANPPT) dressing
Trial: 26884588
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy (IC) with cisplatin, paclitaxel, cetuximab ± everolimus
Trial: 9854662
Drug: Standard analgesic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard analgesic regimen
Trial: 7611214
Drug: Interferon alfa-n3
RxNorm normalized name: Interferon alfa-n3
DrugBank: Interferon alfa-n3 (DB00018)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa-n3 therapy
Trial: 7611214
Drug: Platelet transfusion,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet transfusion, intravenous steroids, and intravenous immunoglobulin
Trial: 7074750
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg every 6 hours
Trial: 31332665
Drug: Core needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Core needle biopsy (CNB) diagnosed papillary neoplasms (PN) with concurrent atypical ductal hyperplasia
Trial: 31332665
Drug: Core needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Core needle biopsy (CNB) diagnosed papillary neoplasms (PN) with concurrent atypical lobular hyperplasia/flat epithelial atypia
Trial: 27960614
Drug: Short-term individual
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term individual shear rate therapy (ISRT)
Trial: 26183582
Drug: Individual music
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual music therapy
Trial: 23383603
Drug: Pancreatin 25,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancreatin 25,000 minimicrospheres (Creon 25000 MMS); 9-15 capsules/day (3 with main meals, 2 with snacks)
Trial: 19249017
Drug: Mindfulness-Based Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-Based Cognitive Therapy (MBCT) delivered in addition to treatment-as-usual (TAU)
Trial: 9586892
Drug: 17-1A antibody
RxNorm normalized name: Peginterferon Beta-1A
DrugBank: Peginterferon beta-1a (DB09122)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 17-1A antibody (900 mg total: 500 mg postoperatively followed by 4 monthly doses of 100 mg)
Trial: 7988180
Drug: Terbutaline (bolus,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (bolus, 0.25 mg; maintenance dose, 5 micrograms/min)
Trial: 25196580
Drug: Pumpkin seed
RxNorm normalized name: PUMPKIN SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pumpkin seed (5 g b.i.d.)
Trial: 25196580
Drug: Pumpkin seed
RxNorm normalized name: PUMPKIN SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pumpkin seed extract (500 mg b.i.d.)
Trial: 23333088
Drug: n-3 PUFA
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFA (2.090 g of EPA and 1.165 g of DHA)
Trial: 18463627
Drug: Citalopram (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (20 mg infused over 30 min)
Trial: 12646793
Drug: Oxymetholone TID
RxNorm normalized name: Oxymetholone
DrugBank: Oxymetholone (DB06412)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxymetholone TID (150 mg/day)
Trial: 12646793
Drug: Oxymetholone BID
RxNorm normalized name: Oxymetholone
DrugBank: Oxymetholone (DB06412)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxymetholone BID (100 mg/day)
Trial: 9346145
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral principles on a pain management program (group therapy)
Trial: 9346145
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral principles on a pain management program (individual therapy)
Trial: 3524463
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy plus immunotherapy with N-CWS and irradiated allogeneic AML cells
Trial: 28691316
Drug: Unwaxed dental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unwaxed dental floss impregnated with 2% chlorhexidine (used twice daily)
Trial: 28691316
Drug: Standard unwaxed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard unwaxed dental floss (used twice daily)
Trial: 27429285
Drug: Negative Pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative Pressure Wound Therapy (NPWT PICO™ dressing)
Trial: 12960179
Drug: Acetazolamide (ACZ)
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide (ACZ) injection
Trial: 9431499
Drug: Oral condition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral condition (verbal instruction only)
Trial: 3531113
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of misonidazole (2.0 gm/m2) and hyperbaric oxygen (3 ATA) with irradiation (6.0 Gy in 30 fractions)
Trial: 29603684
Drug: Pemafibrate (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemafibrate (0.4 mg/day, b.i.d.)
Trial: 24698346
Drug: Retinol (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retinol (7.5 mg RE/d)
Trial: 23227789
Drug: Electro-acupuncture coupled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electro-acupuncture coupled with conventional treatments
Trial: 27354043
Drug: Conventional treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatments alone
Trial: 20682023
Drug: Blood samples
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood samples for lipid status, hormones, insulin, and OGTT
Trial: 2499185
Drug: Mannitol solution
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mannitol solution (142 mOsm/kg)
Trial: 2499185
Drug: Mannitol solution
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mannitol solution (296 mOsm/kg)
Trial: 2499185
Drug: Mannitol solution
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mannitol solution (449 mOsm/kg)
Trial: 2499185
Drug: Mannitol solution
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mannitol solution (704 mOsm/kg)
Trial: 2499185
Drug: Mannitol solution
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mannitol solution (1481 mOsm/kg)